HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

This study will evaluate HCW9302 in patients with moderate to severe alopecia areataMIRAMAR, Fla., Feb. 03, 2025 (GLOBE ...

Pets who've been overlooked at shelters get a "second shot" at adoption thanks to photographer Adam Goldberg whose studio photos showing the animals in their best light have led them to find new ...

In this study, we will focus on understanding the mechanistic bases of altered immunity to infection in an animal model of diet-induced obesity in early life. Caenorhabditis elegans is a genetically ...

Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles. Breakdown of immune privilege in hair follicles leads to ...

Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles. Breakdown of immune privilege in hair follicles leads to ...

The influencer raised an incredible £13,000 for a children's hair loss charity last year after she developed alopecia herself following a series of traumatic events. Speaking to new bombshell ...

ALOPECIA areata (AA) is a prevalent autoimmune condition characterised by sudden, non-scarring hair loss on the scalp or body. Its clinical course is highly unpredictable, ranging from spontaneous ...